Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase in adoption of microarrays in genomics and proteomics, rising prevalence of chronic diseases, and growing applications of protein microarray technology in drug discovery.
The protein microarray market is segmented as below:
By Class Type
- Analytical protein microarrays
- Functional protein microarrays
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the protein microarray market covers the following areas:
- Protein Microarray Market sizing
- Protein Microarray Market forecast
- Protein Microarray Market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
Executive Summary
The following companies are recognized as the key players in the global protein microarray market: Agilent Technologies Inc., Applied Microarrays Inc., Arrayit Corp., Bio Rad Laboratories Inc., BioChain Institute Inc., Cambridge Protein Arrays Ltd., Cepheid Inc., Danaher Corp., Fluidigm Corp., Genotypic Technology Pvt. Ltd., Illumina Inc., LifeSpan BioSciences Inc., Merck and Co. Inc., Molecular Device LLC, Perkin Elmer Inc., RayBiotech Life Inc., SCHOTT AG, Sengenics Corp. LLC, Thermo Fisher Scientific Inc., and US Biomax Inc.Â.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is rising popularity of personalized medicines."
According to the report, one of the major drivers for this market is the increase in adoption of microarrays in genomics and proteomics.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Agilent Technologies Inc.
- Applied Microarrays Inc.
- Arrayit Corp.
- Bio Rad Laboratories Inc.
- BioChain Institute Inc.
- Cambridge Protein Arrays Ltd.
- Cepheid Inc.
- Danaher Corp.
- Fluidigm Corp.
- Genotypic Technology Pvt. Ltd.
- Illumina Inc.
- LifeSpan BioSciences Inc.
- Merck and Co. Inc.
- Molecular Device LLC
- Perkin Elmer Inc.
- RayBiotech Life Inc.
- SCHOTT AG
- Sengenics Corp. LLC
- Thermo Fisher Scientific Inc.
- US Biomax Inc.Â